Effect of apoprotein-CII on efficacy of chylomicron-triacylglycerol as substrate for working heart.
Wang
X
X
Nuffield Department of Anaesthetics, University of Oxford, Radcliffe Infirmary, UK.
Evans
R D
RD
D053304:Apolipoprotein C-II; D001056:Apolipoproteins C / Q000097:blood / Q000494:pharmacology*; D002914:Chylomicrons / Q000378:metabolism*; D006321:Heart / Q000502:physiology*; D066298:In Vitro Techniques; D007700:Kinetics; D008066:Lipolysis / Q000187:drug effects*; D008071:Lipoprotein Lipase / Q000378:metabolism*; D009206:Myocardium / Q000378:metabolism*; D019301:Oleic Acid / Q000378:metabolism; D010477:Perfusion; D013379:Substrate Specificity; D014304:Triolein / Q000378:metabolism
D053304:Apolipoprotein C-II; D001056:Apolipoproteins C; D002914:Chylomicrons; D014304:Triolein; D019301:Oleic Acid; D008071:Lipoprotein Lipase